Skip to main content
Log in

Quantitative Tc-99m sestamibi attenuation-corrected SPECT: Development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population

  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

A gender-independent stress normal database and criteria for abnormality for attenuation-corrected rest-stress technetium 99m sestamibi same-day myocardial perfusion imaging were developed by evaluation of 112 patients, validated against an obese population of 95 patients from four different clinical sites, and compared with conventional gender-matched database quantification of non-attenuation-corrected studies.

Methods and Results

These 95 validation patients (63 men) were used for prospective quantitative evaluation (mean weight, 213 ± 57 lb; mean body mass index, 32 ± 9 kg/m2). This group included 21 patients (12 men) with a lower than 5% likelihood of coronary artery disease (mean weight, 226 ± 72 lb; mean body mass index, 34 ± 13 kg/m2) and 74 who underwent cardiac catheterization within 2 months (35 with normal coronaries or coronary lesions <70%). These studies were processed twice, once by use of conventional reconstruction and genderspecific database quantification and a second time by use of attenuation correction and a single gender-independent attenuation-corrected normal database. The attenuation-corrected normal database and criteria for abnormality were developed by evaluation of 48 and 78 patients, respectively. No statistically significant differences were found when comparing attenuationcorrected perfusion distributions of normal men and women, whereas significant differences were found in the same uncorrected studies. Compared with quantitative analysis of the uncorrected studies, quantitative analysis of the attenuation-corrected studies by use of a gender-independent normal database demonstrated a significant improvement in normalcy rate (90% vs 52%, P =.006) and specificity (57% vs 29%, P = 015) in this obese population at no significant loss in sensitivity (90% vs 97%, P = not significant).

Conclusion

Attenuation-corrected studies can be quantified with a single gender-independent normal database and a single criterion for abnormality without loss of sensitivity and with significantly better specificity and normalcy rate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905–14.

    PubMed  CAS  Google Scholar 

  2. Beller GA. Clinical nuclear cardiology: detection of coronary#@#artery disease. Philadelphia: Saunders; 1995.

    Google Scholar 

  3. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation 1998;97:535–43.

    PubMed  CAS  Google Scholar 

  4. Iskander S, Iskandrian AE. Risk assessment using single photon emission computed tomography technetium-99m-sestamibi imaging. J Am Coll Cardiol 1998;32:57–62.

    Article  PubMed  CAS  Google Scholar 

  5. DePuey EG, Garcia EV. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts. J Nucl Med 1989;30:441–9.

    PubMed  CAS  Google Scholar 

  6. Corbett JR, Ficaro EP. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol 1999;6:54–68.

    Article  PubMed  CAS  Google Scholar 

  7. Esquerre JP, Coca FJ, Martinez SJ, Guiraud RF. Prone decubitus: a solution to inferior wall attenuation in thallium-201 myocardial tomography. J Nucl Med 1989;30:398–401.

    PubMed  CAS  Google Scholar 

  8. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995;36:952–5.

    PubMed  CAS  Google Scholar 

  9. Garcia EV. Quantitative myocardial perfusion single-photon emission#@#computed tomographic imaging: quo vadis? (Where do we go#@#from here?). J Nucl Cardiol 1994;1:83–93.

    Article  PubMed  CAS  Google Scholar 

  10. Garcia EV, Van Train K, Maddahi J, et al. Quantification of rotational thallium-201 myocardial tomography. J Nucl Med 1985; 26:17–26.

    PubMed  CAS  Google Scholar 

  11. Depasquale EE, Nody AC, DePuey EG, et al. Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 1988;77:316–27.

    PubMed  CAS  Google Scholar 

  12. Van Train KF, Areeda J, Garcia EV, et al. Quantitative same-day rest-stress technetium-99m sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494–502.

    PubMed  Google Scholar 

  13. Eisner RL, Tamas MJ, Cloninger K, et al. Normal SPECT thallium-201 bull’s-eye display: gender differences. J Nucl Med 1988;29:1901–9.

    PubMed  CAS  Google Scholar 

  14. Ficaro EP, Fessler JA, Shreve PD, et al. Simultaneous transmission/ emission myocardial perfusion tomography: diagnostic accuracy of attenuation-corrected 99m technetium-sestamibi singlephoton emission computed tomography. Circulation 1996;93:463- 73.

    PubMed  CAS  Google Scholar 

  15. Cullom SJ, Case JA, Bateman TM. Attenuation correction of cardiac SPECT: clinical and development changes. J Nucl Med 2000;41:860–2.

    Google Scholar 

  16. Links JM, Becker LC, Rigo P, et al. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicenter trial. J Nucl Cardiol 2000;7:414–25.

    Article  PubMed  CAS  Google Scholar 

  17. Shotwell M, Singh BM, Fortman C, et al. Improved coronary disease detection with quantitative attenuation-corrected Tl-201 images. J Nucl Cardiol 2002;9:52–62.

    Article  PubMed  Google Scholar 

  18. Hendel RC, Corbett JR, Cullom JC, et al. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: a joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol 2002;9:135–43.

    Article  PubMed  Google Scholar 

  19. Galt JR, Blais M, Cullom SJ, Vansant JP, Garcia EV.Quality control of transmission scans for attenuation correction in cardiac SPECT [abstract]. J Nucl Med 1999;40:286P.

    Google Scholar 

  20. Case JA, Cullom SJ, Bateman TM. Noise reduction in transmission computed tomography for cardiac SPECT attenuation correction using a gamma prior [abstract]. J Nucl Med 1998;39:181P.

    Google Scholar 

  21. VantagePRO user’s manual. Milpitas, (CA): ADAC Laboratories;#@#2000.

  22. Case JA, Bateman TM, Cullom SJ, et al. Impact of transmission scan reconstruction using an iterative algorithm (BITGA) versus FBP: clinical appearance of attenuation-corrected myocardial perfusion SPECT images [abstract]. J Nucl Med 2001;42:51P.

    Google Scholar 

  23. Case JA, Pan TS, O’Brian-Penney B, et al. Reduction of truncation artifacts in fan beam transmission imaging using a spatially varying gamma prior. IEEE Trans Nucl Sci 1995;42:1310–20.

    Article  Google Scholar 

  24. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350–8.

    PubMed  CAS  Google Scholar 

  25. Tan P, Bailey DL, Meikle SR, et al. A scanning line source for simultaneous emission and transmission measurements in SPECT. J Nucl Med 1993;34:1752–60.

    PubMed  CAS  Google Scholar 

  26. Berman DS, Hayes SW, Germano G. Assessment of myocardial#@#perfusion and viability with technetium-99m perfusion agents. In:#@#DePuey EG, Garcia EV, Berman DS, editors. Cardiac SPECT#@#imaging. Philadelphia: Lippincott Williams & Wilkins; 2001. p.#@#179–210.

    Google Scholar 

  27. Hansen CL, Woodhouse S, Kramer M. Effect of patient obesity on#@#the accuracy of thallium-201 myocardial perfusion imaging. Am J#@#Cardiol 2000;85:749–52.

    Article  CAS  Google Scholar 

  28. Van Train KF, Berman DS, Garcia EV, et al. Quantitative analysis of stress thallium-201 myocardial scintigrams: a multicenter trial. J Nucl Med 1986;27:17–25.

    PubMed  Google Scholar 

  29. Van Train KF, Garcia EV, Maddahi J, et al. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium- 99m-sestamibi myocardial tomograms. J Nucl Med 1994;35:609–18.

    PubMed  Google Scholar 

  30. Links JM, DePuey EG, Taillefer R, Becker LC. Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT. J Nucl Cardiol 2002;9:183–7.

    Article  PubMed  Google Scholar 

  31. Rozanski A, Diamond GA, Berman D, et al. The declining specificity of exercise radionuclide ventriculography. N Engl J Med 1983;309:518–22.

    PubMed  CAS  Google Scholar 

  32. Rozanski A. Referral bias and the efficacy of radionuclide stress tests: problems and solutions [editorial]. J Nucl Med 1992;33:2074–9.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Dr Grossman was funded in part by a grant from CAPES-Brazilian Research Agency through the Cardiovascular Science and Cardiology Graduate Program from the Federal University of Rio Grande do Sul, Brazil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grossman, G.B., Garcia, E.V., Bateman, T.M. et al. Quantitative Tc-99m sestamibi attenuation-corrected SPECT: Development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol 11, 263–272 (2004). https://doi.org/10.1016/j.nuclcard.2004.02.007

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.nuclcard.2004.02.007

Keywords

Navigation